SCHEMBL29392686

SCHEMBL29392686

Cc1cc(=O)[nH]c(SCC(=O)c2cccc3ccccc23)n1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC6 Q9UBN7 8/20 0.68
▸ POLB P06746 2/20 0.63
▸ CYP1A2 P05177 1/20 0.61
▸ CYP2C9 P11712 1/20 0.61
▸ CYP2C19 P33261 1/20 0.61
▸ LMNA P02545 2/20 0.59
▸ TSHR P16473 2/20 0.59
▸ HDAC3 O15379 2/20 0.59
▸ HDAC1 Q13547 2/20 0.59
▸ HDAC2 Q92769 2/20 0.59
▸ CA12 O43570 2/20 0.58
▸ CA1 P00915 2/20 0.58
▸ CA2 P00918 2/20 0.58
▸ CA6 P23280 2/20 0.58
▸ CA7 P43166 2/20 0.58
▸ CA13 Q8N1Q1 2/20 0.58
▸ HDAC5 Q9UQL6 2/20 0.58
▸ ALDH1A1 P00352 2/20 0.58
▸ HSP90AA1 P07900 1/20 0.58
▸ HSP90AB1 P08238 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17382991 0.76 CYP1A2 (1.00) HDAC6POLBCYP1A2CYP2C9CYP2C19
SCHEMBL27089959 0.76 MAPT (0.53) POLBCYP1A2CYP2C9CYP2C19LMNA
SCHEMBL17382815 0.73 HDAC6 (1.00) HDAC6POLBCYP1A2CYP2C9CYP2C19
SCHEMBL10350929 0.70 ALDH1A1 (0.64) POLBCYP1A2CYP2C9LMNATSHR
SCHEMBL18063501 0.70 HPGD (0.73) HDAC6POLBLMNATSHRALDH1A1
SCHEMBL15709357 0.70 KMT2A (0.72) POLBLMNATSHRALDH1A1GAA
SCHEMBL30919323 0.70 KMT2A (0.72) POLBLMNATSHRALDH1A1GAA
SCHEMBL17382809 0.69 NPC1 (0.69) HDAC6POLBCYP1A2CYP2C9CYP2C19
SCHEMBL1890037 0.68 GPR84 (0.67) HDAC6POLBCYP1A2CYP2C9CYP2C19
SCHEMBL17382803 0.68 HDAC6 (1.00) HDAC6POLBCYP1A2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025093674-A2 METHOD FOR EXPANDING LIVER CELLS MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2025-05-08 — — WO claimed
US-20240016772-A1 Compositions And Methods Comprising D-Cysteine Or A D-Derivative Thereof UNIVERSITE DE GENEVE (CH) 2024-01-18 — — US claimed
EP-4203938-A1 COMPOSITIONS AND METHODS COMPRISING D-CYSTEINE OR A D-DERIVATIVE THEREOF Université de Genève (CH) 2023-07-05 — — EP claimed
WO-2022043265-A1 COMPOSITIONS AND METHODS COMPRISING D-CYSTEINE OR A D-DERIVATIVE THEREOF UNIVERSITÉ DE GENÈVE (CH) 2022-03-03 — — WO claimed
WO-2025093674-A2 METHOD FOR EXPANDING LIVER CELLS MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2025-05-08 — — WO disclosed
CN-116019811-B Application of GSK-J4 in preparation of medicine for resisting gram positive bacteria infection 华中科技大学协和深圳医院 2024-04-12 — — CN disclosed
CN-116019811-A Application of GSK-J4 in preparation of medicine for resisting gram positive bacteria infection 华中科技大学协和深圳医院 2023-04-28 — — CN disclosed
CN-113106066-B Sarcoma cell culture medium and method for producing Matrigel stock solution in vitro by using culture medium 杭州艾名医学科技有限公司 2022-08-23 — — CN disclosed
Send feedback